ABSTRACT. Calcitonin (CT) has been shown to have various functions including osteoclast activity and calcium and phosphorus metabolism in mammals. In the present study, we measured the amounts of CT mRNA in the mouse brain, liver, kidney, heart and testis at various development stages, 14 days post-coitum (dpc), 17-dpc, newborn, 1 week and 8 weeks (adult), using real-time PCR. In the brain and kidney, the amount of CT mRNA decreased with development. In the testis, elevated amounts were observed at 17-dpc and 8 weeks. In the liver, the amount increased from the 14 dpc embryo to newborn stage and then decreased. In the heart, elevated amounts were observed at 17-dpc. Additionally, the CT antisense transcript was determined using a modified RT-PCR and nucleotide sequencing in the present study. Organs with high mRNA expressions were examined for localization of transcripts using in situ hybridization. The CT sense and antisense transcripts in the 14 dpc brain were mainly localized in the mesencephalon. In the pre-and postnatal stages, sense and antisense transcripts were shown to exist rather uniformly in the kidney, heart, liver and testis. In the 17-dpc rib and thyroid lobe and the adult ovary, the sense and antisense transcripts were found to be densely localized. KEY WORDS: calcitonin, in situ hybridization, mouse, sense/antisense transcripts.J. Vet. Med. Sci. 71 (5): [561][562][563][564][565][566][567][568] 2009 Calcitonin (CT) is a 32 amino acid peptide hormone that has been shown to participate in osteoclast activity and reabsorption of calcium and phosphorus through target organ comprised of the bone and kidney in mammals. CT is mainly produced in parafollicular cells (C cells) in the thyroid gland and is produced in a wide variety of other tissues [12]. Currently, CT is a therapeutic agent for treatment of bone diseases such as osteoporosis and Paget's disease [10,16]. Expression of CT in tissue from the brain, prostate and uterus has been reported [3][4][5], and this suggests that it has additional functions other than those for osteoclasts and the kidney. As supporting evidence for additional functions, the CT expression levels have been shown to be related with tumorigenicity of prostate cancer [15] and to be increased in the pregnant rat uterus during implantation [4]. Furthermore, treatment with antisense olignucleotide of CT mRNA severely impairs embryo implantation [18].In the past several years, the number of sense and antisense pair transcripts reported has sharply increased [7]. Due to the increase in the number of these studies, researchers have initiated investigations of not only of the localization of antisense transcripts but also of regulation of sense transcripts with their antisense transcripts in order to more fully understand the molecular interaction occurring in individual loci, cells and tissues. Changes in the expression levels of each non-coding RNA have been described for complex diseases such as cancer [1,14,17] and neurological diseases [11].However, little is known about th...